Vinay Kumar Sonali, Kumar Vinay, Mishra Sanjay, Sati Alok
Associate Professor (Ophthalmology), Army Hospital (R&R), Delhi Cantt, India.
Professor & Head (Anatomy), World College of Medical Sciences Research & Hospital, Jhajjar, Haryana, India.
Med J Armed Forces India. 2023 Sep-Oct;79(5):584-589. doi: 10.1016/j.mjafi.2021.09.007. Epub 2021 Nov 28.
The treatment of epiphora has undergone tremendous change in the past, and minimally invasive techniques are being preferred over traditional surgical options. One of them is the use of Inj Botulinum toxin, but there are very few studies that have explored its role in treating post-traumatic epiphora. This study was undertaken to find out the safety and efficacy of injection Botulinum toxin in treating epiphora due to canalicular obstruction following trauma.
A longitudinal interventional study was done, and a total of 50 patients were recruited. All patients were subjected to Inj Botulinum toxin in the lacrimal gland (10 units). The study was done for a period of 6 months, and patients were followed up for a period of another 6 months. Changes in Munk score, Schirmer test, and tear meniscus height were considered the main outcome measures.
In our study, there were 38 males and 12 females. The age of the patients varied from 24 yrs to 67 yrs. Inj Botulinum toxin was found to be effective in 80% (n = 40/50) of cases as they reported a reduction in watering from eyes after administration of this injection. The complication associated with this treatment was minimal in our study as four patients reported diplopia, whereas two patients developed Ptosis that resolved spontaneously within two months.
Inj Botulinum toxin was found to be effective in epiphora caused by canalicular obstruction due to trauma. This treatment should be considered as an alternative treatment modality as it often leads to satisfactory reduction in epiphora in patients with less complications compared to surgical intervention.
过去泪溢的治疗方法发生了巨大变化,微创技术比传统手术选择更受青睐。其中之一是使用注射用肉毒杆菌毒素,但很少有研究探讨其在治疗创伤后泪溢中的作用。本研究旨在探讨注射用肉毒杆菌毒素治疗外伤后泪小管阻塞所致泪溢的安全性和有效性。
进行了一项纵向干预研究,共招募了50名患者。所有患者均在泪腺注射肉毒杆菌毒素(10单位)。研究为期6个月,患者随后又接受了6个月的随访。主要观察指标为蒙克评分、泪液分泌试验和泪膜高度的变化。
在我们的研究中,男性38例,女性12例。患者年龄在24岁至67岁之间。发现注射用肉毒杆菌毒素在80%(n = 40/50)的病例中有效,因为他们报告注射后眼部分泌物减少。在我们的研究中,与这种治疗相关的并发症很少,有4例患者报告出现复视,而2例患者出现上睑下垂,在两个月内自行缓解。
发现注射用肉毒杆菌毒素对外伤性泪小管阻塞所致泪溢有效。这种治疗应被视为一种替代治疗方式,因为与手术干预相比,它通常能使泪溢患者得到满意的缓解,且并发症较少。